[go: up one dir, main page]

WO2001002591A1 - Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures - Google Patents

Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures Download PDF

Info

Publication number
WO2001002591A1
WO2001002591A1 PCT/EP2000/006223 EP0006223W WO0102591A1 WO 2001002591 A1 WO2001002591 A1 WO 2001002591A1 EP 0006223 W EP0006223 W EP 0006223W WO 0102591 A1 WO0102591 A1 WO 0102591A1
Authority
WO
WIPO (PCT)
Prior art keywords
organism
fatty acids
nucleic acid
desaturase
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/006223
Other languages
German (de)
English (en)
Inventor
Ernst Heinz
Thomas Girke
Jodi Scheffler
Oswaldo Da Costa E Silva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
BASF Plant Science GmbH
Original Assignee
BASF SE
BASF Plant Science GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10030976A external-priority patent/DE10030976A1/de
Application filed by BASF SE, BASF Plant Science GmbH filed Critical BASF SE
Priority to EP00952997A priority Critical patent/EP1190080A1/fr
Priority to CA002378423A priority patent/CA2378423A1/fr
Priority to AU65607/00A priority patent/AU776417B2/en
Priority to US10/019,048 priority patent/US8835715B1/en
Publication of WO2001002591A1 publication Critical patent/WO2001002591A1/fr
Anticipated expiration legal-status Critical
Priority to US14/268,700 priority patent/US9611441B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone

Definitions

  • the present invention relates to an improved process for the production of unsaturated fatty acids and a process for the production of triglycerides with an increased content of unsaturated fatty acids.
  • the invention relates to the production of a transgenic organism, preferably a transgenic plant or a transgenic microorganism with an increased content of fatty acids, oils or lipids with ⁇ 6 double bonds due to the expression of a ⁇ 6-desaturase from moss.
  • the invention also relates to transgenic organisms which contain a ⁇ 6-desaturase gene, and to the use of the unsaturated fatty acids or triglycerides produced in the process with an increased content of unsaturated fatty acids.
  • Fatty acids and triglycerides have a variety of uses in the food industry, animal nutrition, cosmetics and pharmaceuticals. Depending on whether it is free saturated or unsaturated fatty acids or triglycerides with an increased content of saturated or unsaturated fatty acids, they are suitable for a wide variety of applications, for example polyunsaturated fatty acids are added to baby food to increase the nutritional value.
  • the various fatty acids and triglycerides are mainly obtained from microorganisms such as Mortierella or from oil-producing plants such as soybean, rapeseed, sunflower and others, where they are generally obtained in the form of their triacylglycerides. But they can also be obtained from animals such as fish.
  • the free fatty acids are advantageously produced by saponification.
  • oils with saturated or unsaturated fatty acids are preferred.
  • lipids with unsaturated fatty acids especially polyunsaturated fatty acids, are preferred in human nutrition because they have a positive influence on the cholesterol level in the blood and thus on the possibility of heart disease.
  • Unsaturated fatty acids are also said to have a positive effect on carcinogenesis. They are also important raw materials for the synthesis of compounds that are important biological processes within the Control the organism. They are therefore used in various diet foods or medications.
  • WO 94/11516 claims a ⁇ 12 desaturase. ⁇ 6 desaturases are described in Girke et al. (The Plant Journal, 15, 1998: 39-48), Napier et al. (Biochem. J., 330, 1998: 611-614), Murata et al. (Biosynthesis of ⁇ -linolenic acid in cyanobacterium spirulina
  • membrane-bound proteins are very difficult to isolate and characterize (McKeon et al., Methods in Enzymol. 71, 1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26, 1988: 777-792).
  • membrane-bound desaturases are characterized by incorporation into one
  • the object was therefore to provide a process for the production of unsaturated fatty acids using genes which code, for example, for desaturase enzymes and which are involved in the synthesis of polyunsaturated fatty acids in the seeds of an oilseed, and thus to increase the content of polyunsaturated fatty acids.
  • This object was achieved by a process for the production of unsaturated fatty acids, characterized in that at least one isolated nucleic acid sequence which codes for a polypeptide with ⁇ -desaturase activity, selected from the group:
  • the attracted organism is introduced into an organism, this organism is attracted, the attracted organism containing at least 1 mol% of unsaturated fatty acids based on the total fatty acid content in the organism.
  • Cultivation of the organism is to be understood as the cultivation of plants as well as the cultivation of eukaryotic or prokaryotic microorganisms such as bacteria, yeasts, fungi, ciliates, algae, cyanobacteria, animal or plant cells or cell groups or the cultivation of animals.
  • eukaryotic or prokaryotic microorganisms such as bacteria, yeasts, fungi, ciliates, algae, cyanobacteria, animal or plant cells or cell groups or the cultivation of animals.
  • the organisms obtained in the process according to the invention generally contain unsaturated fatty acids in the form of bound fatty acids, that is to say the unsaturated fatty acids are predominantly in the form of their mono-, di- or triglycerides, glycolipids, lipoproteins or phospholipids such as oils or lipids or other fatty acids bound as esters or amides.
  • Free fatty acids are also contained in the organisms in the form of the free fatty acids or in the form of their salts.
  • the free or bound unsaturated fatty acids advantageously contain, compared to the starting organisms, an increased content of fatty acids with ⁇ 6 double bonds, such as ⁇ -linolenic acid.
  • the organisms obtained by cultivation in the process according to the invention and the unsaturated fatty acids contained in them can be used directly, for example, for the production of pharmaceutical preparations, agrochemicals, animal feeds or foods or after isolation from the organisms. All stages of the purification of the unsaturated fatty acids can be used, ie from crude extracts of the fatty acids to completely purified fatty acids are suitable for the production of the aforementioned products.
  • the bound fatty acids can be released from, for example, the oils or lipids, for example via basic hydrolysis, for example with NaOH or KOH. These free fatty acids can be used directly in the mixture obtained or after further purification for the production of pharmaceutical preparations, agrochemicals, animal feeds or foods.
  • the bound or free fatty acids can also be used for transesterification or esterification, for example with other mono-, di- or triglycerides or glycerol, in order to increase the proportion of unsaturated fatty acids in these compounds, for example in the triglycerides.
  • a further subject of the invention is a process for the production of triglycerides with an increased unsaturated fatty acid content by triglycerides with saturated or unsaturated or saturated and unsaturated fatty acids with at least one of the protein which is encoded by the sequence SEQ ID NO: 2 , incubated.
  • the process is advantageously carried out in the presence of compounds which can absorb or give off reduction equivalents. The fatty acids can then be released from the triglycerides.
  • organisms for the processes mentioned are plants such as arabidopsis, barley, wheat, rye, oats, corn, soybeans, rice, cotton, sugar beet, tea, carrots, peppers, canola, sunflower, flax, hemp, potatoes, triticale, tobacco, Tomato, rapeseed, coffee, tapioca, cassava, arrowroot, tagetes, alfalfa, peanut, castor bean, coconut, oil palm, safflower (Carthamus tinctorius), lettuce and the various tree, nut and wine species, or cocoa beans, microorganisms such as fungi Mortierella, Saprolegnia or Pythium, bacteria such as the genus Escherichia, cyanobacteria, algae or protozoa such as dinoflagellates such as Crypthecodinium.
  • plants such as arabidopsis, barley, wheat, rye, oats, corn, soybeans, rice, cotton, sugar beet
  • Organisms which can naturally synthesize oils in large quantities such as microorganisms such as fungi such as Mortierella alpina, Pythium insidiosum or plants such as soybean, rapeseed, coconut, oil palm, canola, safflower (Carthamus tinctorius), castor oil, calendula, linseed, borage, peanut, are preferred , Cocoa bean or sunflower, soya, rape or sunflower are particularly preferred.
  • microorganisms such as Mortierella alpina, Pythium insidiosum or plants such as soybean, rapeseed, coconut, oil palm, canola, safflower (Carthamus tinctorius), castor oil, calendula, linseed, borage, peanut, are preferred , Cocoa bean or sunflower, soya, rape or sunflower are particularly preferred.
  • Microorganisms such as bacteria, fungi, ciliates, plant or animal cells are usually in a liquid medium containing a carbon source mostly in the form of sugars, a nitrogen source mostly in the form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as iron, Manganese, magnesium salts and possibly vitamins contains, at temperatures between 0 ° C and 100 ° C, preferably between 10 ° C to 60 ° C, depending on the organism, oxygen or in the absence of oxygen.
  • the pH of the nutrient liquid can be kept at a fixed value, i.e.
  • the pH is regulated during cultivation or the pH is not regulated and changes during cultivation.
  • the cultivation can be batch-wise, semi-batch wise or continuous. Nutrients can be added at the start of the fermentation or fed semi-continuously or continuously. Cultivation on solid media is also possible.
  • plants After transformation, plants are generally regenerated and then grown or grown as usual. This can be done in the greenhouse or outdoors.
  • the lipids are usually obtained from the organisms.
  • the organisms can first be digested after harvesting or used directly.
  • the lipids are advantageously mixed with suitable solvents such as apolar
  • Solvents such as hexane or ethanol, isopropanol or mixtures such as hexane / isopropanol, phenol / chloroform / isoamyl alcohol extracted at temperatures between 0 ° C to 80 ° C, preferably between 20 ° C to 50 ° C.
  • the biomass is usually extracted with an excess of solvent, for example an excess of solvent to biomass of 1: 4.
  • the solvent is then removed, for example by distillation.
  • the extraction can also be carried out with supercritical CO 2 . After extraction, the remaining biomass can be removed, for example, by filtration.
  • the crude oil obtained in this way can then be further purified, for example by removing turbidity by adding polar solvents such as acetone or chloroform and then filtering or centrifuging. Further purification using chromatographic processes, distillation or crystallization is also possible.
  • Another object of the invention are unsaturated fatty acids and trigylcerides with an increased content of unsaturated fatty acids, which were prepared by the above methods, and their use for the production of food, animal feed, cosmetics or pharmaceuticals. For this purpose, they are added to the food, animal feed, cosmetics or pharmaceuticals in the usual amounts.
  • a ⁇ 6-desaturase from moss in organisms such as fungi, bacteria, animals or plants, preferably fungi, bacteria and plants, particularly preferably in plants, very particularly preferably in oil crop plants such as rapeseed, canola, linseed, soybean, sunflower , Borage, castor, oil palm, safflower (Carthamus tinctorius), coconut, peanut or cocoa bean receive higher levels of unsaturated fatty acids such as ⁇ -linolenic acid.
  • crops such as corn, wheat, rye, oats, triticale, rice, barley, alfalfa or bush plants (coffee, cocoa, tea) is also advantageous.
  • the expression of a gene which codes for a ⁇ -6-desaturase from moss in the above-mentioned organisms enables contents of unsaturated fatty acids in the organisms of at least 1 mol%, preferably at least 3 mol%, particularly preferably at least 4 mol -%, very particularly preferably at least 5 mol% can be achieved.
  • Derivatives are, for example, functional homologues of the enzymes encoded by SEQ ID NO: 1 or their enzymatic activity, that is to say enzymes which catalyze the same enzymatic reactions as those of SEQ ID NO: 1. These genes also enable advantageous production of unsaturated fatty acids with double bonds in the ⁇ 6 position. Below unsaturated fatty acids are double or polyunsaturated fatty acids which have double bonds, to understand. The double bonds can be conjugated or non-conjugated. The sequence mentioned in SEQ ID NO: 1 codes for an enzyme which has a ⁇ 6-desaturase activity.
  • the enzyme ⁇ 6-desaturase according to the invention advantageously introduces a cis double bond in position C 6 ⁇ C into fatty acid residues of glycerolipids (see SEQ ID NO: 1).
  • the enzyme also has a ⁇ 6-desaturase activity which advantageously only introduces a cis double bond in the 10 position Cg-C into fatty acid residues of glycerolipids.
  • the enzyme with the sequence given in SEQ ID NO: 1, which is a monofunctional ⁇ 6 desaturase also has this activity.
  • nucleic acid sequence (s) used in the method according to the invention can advantageously be used for the isolation of further genomic sequences via homology screening.
  • the derivatives mentioned can be isolated, for example, from other organisms in eukaryotic organisms such as plants such as specifically mosses, dinoflagellates or fungi.
  • derivatives or functional derivatives include
  • allelic variants which have at least 50% homology at the derived amino acid level, advantageously at least 70% homology, preferably at least 80% homology, particularly preferably at least 85% homology, very particularly preferably 90% homology ,
  • amino acid sequence derived from the nucleic acids mentioned can be found in sequence SEQ ID NO: 2.
  • Homology means identity, that is, the amino acid sequences are at least
  • sequences according to the invention are at least 65% homologous, preferably at least 70%, particularly preferably 75%, very particularly preferably at least 80%.
  • allele variants comprise in particular functional variants which can be obtained by deleting, inserting or substituting nucleotides from the sequence shown in SEQ ID NO: 1, wherein the enzymatic activity of the derived synthesized proteins is retained.
  • Such DNA sequences can be started from the DNA sequence described in SEQ ID NO: 1 or parts thereof
  • Isolate sequences for example with conventional hybridization methods or the PCR technique, from other eukaryotes such as those mentioned above. These DNA sequences hybridize to the sequences mentioned under standard conditions. Short oligonucleotides, for example of the conserved regions, which can be determined by comparison with other desaturase genes in a manner known to the person skilled in the art, are advantageously used for the hybridization. The histidine box sequences are advantageously used. However, longer fragments of the nucleic acids according to the invention or the complete sequences can also be used for the hybridization. These standard conditions vary depending on the nucleic acid used: oligonucleotide, longer fragment or complete sequence or depending on the type of nucleic acid DNA or RNA used for the hybridization. For example, the melting temperatures for DNA: DNA hybrids are approx. 10 ° C lower than those of DNA: RNA hybrids of the same length.
  • DNA hybrids are advantageously 0.1 ⁇ SSC and temperatures between approximately 20 ° C. to 45 ° C., preferably between approximately 30 ° C. to 45 ° C.
  • RNA hybrids the hybridization conditions are advantageously 0.1 x SSC and temperatures between about 30 C C and 55 ° C, preferably between about 45 ° C to 55 ° C. These specified temperatures for the hybridization are, for example, calculated melting temperature values for a nucleic acid with a length of approx. 100 nucleotides and a G + C content of 50% in the absence of formamide.
  • the experimental conditions for DNA hybridization are in relevant textbooks of genetics such as Sambrook et al. , "Molecular Cloning", Cold Spring Harbor Laboratory, 1989, and can be calculated according to formulas known to the person skilled in the art, for example depending on the length of the nucleic acids, the type of hybrid or the G + C content. The person skilled in the art can obtain further information on hybridization from the following textbooks: Ausubel et al.
  • homologs of the sequence SEQ ID No: 1 are furthermore to be understood, for example, as eukaryotic homologs, shortened sequences, single-stranded DNA of the coding and non-coding DNA sequence or RNA of the coding and non-coding DNA sequence.
  • homologs of the sequence SEQ ID NO: 1 are to be understood as derivatives such as promoter variants. These variants can be changed by one or more nucleotide exchanges, by insertion (s) and / or deletion (s), but without the functionality or effectiveness of the promoters being impaired. Furthermore, the effectiveness of the promoters can be increased by changing their sequence, or completely replaced by more effective promoters, including organisms of other species.
  • Derivatives are also advantageously to be understood as variants whose nucleotide sequence in the range -1 to -2000 before the start codon has been changed such that the gene expression and / or the protein expression is changed, preferably increased. Derivatives are also to be understood as variants that were changed at the 3 'end.
  • the nucleic acid sequences which code for a ⁇ 6-desaturase can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components, and can consist of different heterologous ⁇ 6-desaturase gene segments from different organisms.
  • synthetic nucleotide sequences with codons are generated which are preferred by the corresponding host organisms, for example plants. This usually leads to optimal expression of the heterologous genes.
  • plant preferred codons can be determined from the highest protein frequency codons expressed in most interesting plant species.
  • Corynebacterium glutamicum is given in: Wada et al. (1992) Nucleic Acids Res. 20: 2111 to 2118). Such experiments can be carried out using standard methods and are known to the person skilled in the art.
  • Functionally equivalent sequences which code for the ⁇ 6-desaturase gene are those derivatives of the sequence according to the invention which, despite the differing nucleotide sequence, are still the desired ones Functions, that is, possess the enzymatic activity of the proteins.
  • Functional equivalents thus include naturally occurring variants of the sequences described here, as well as artificial, for example chemical nucleotide sequences obtained by chemical synthesis and adapted to the codon use of a plant.
  • artificial DNA sequences are suitable as long as, as described above, they impart the desired property, for example increasing the content of ⁇ 6 double bonds in fatty acids, oils or lipids in the plant by overexpression of the ⁇ 6 desaturase gene in crop plants.
  • Such artificial DNA sequences can be determined, for example, by back-translating proteins constructed using molecular modeling, which have ⁇ 6-desaturase activity, or by in vitro selection. Possible techniques for the in vitro evolution of DNA to change or improve the DNA sequences are described in Patten, P.A. et al. , Current Opinion in Biotechnology 8, 724-733 (1997) or Moore, J.C. et al., Journal of Molecular Biology 272, 336-347 (1997).
  • Coding DNA sequences which are obtained by back-translating a polypeptide sequence in accordance with the odon usage specific for the host plant are particularly suitable.
  • the specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
  • Suitable equivalent nucleic acid sequences are sequences which code for fusion proteins, part of the fusion protein being a ⁇ 6-desaturase polypeptide or a functionally equivalent part thereof.
  • the second part of the fusion protein can e.g. be another polypeptide with enzymatic activity or an antigenic polypeptide sequence that can be used to detect ⁇ 6-desaturase expression (e.g. mye-tag or his-tag).
  • this is preferably a regulatory protein sequence, such as e.g. a signal sequence for the ER that directs the ⁇ 6-desaturase protein to the desired site of action.
  • the ⁇ 6-desaturase genes can advantageously be combined in the method according to the invention with other genes of fatty acid biosynthesis.
  • examples of such genes are acetyltransferases, further desaturases or elongases of unsaturated or saturated fatty acids as described in WO 00/12720.
  • the combination with, for example, NADH cytochrome B5 reductases is advantageous, which can absorb or release reduction equivalents.
  • proteins used in the method according to the invention are to be understood as proteins which contain an amino acid sequence shown in the sequence SEQ ID NO: 2 or a sequence obtainable therefrom by substitution, inversion, insertion or deletion of one or 5 more amino acid residues, the enzymatic activity of the protein shown in SEQ ID NO: 2 is retained or is not significantly reduced. Not significantly reduced is to be understood as meaning all enzymes which are still at least 10%, preferably 20%, particularly preferred
  • amino acids can be replaced by those with similar physicochemical properties (space filling, basicity, hydrophobicity, etc.).
  • arginine residues against lysine residues valine residues against isoleucine
  • amino acids 15 residues or aspartic acid residues exchanged for glutamic acid residues.
  • one or more amino acids can also be interchanged, added or removed in their order, or several of these measures can be combined with one another.
  • Derivatives are also to be understood as functional equivalents which in particular also include natural or artificial mutations of an originally isolated sequence coding for ⁇ 6-desaturase, which furthermore show the desired function, that
  • Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
  • the present invention also encompasses those nucleotide sequences which are obtained by modifying the ⁇ 6-desaturase nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also be the insertion of further restriction enzyme interfaces.
  • nucleic acid sequences used in the method according to the invention are advantageously inserted into an expression cassette for introduction into a host organism.
  • the nucleic acid sequences can also be introduced directly into the host organism.
  • the nucleic acid sequence can advantageously be, for example, a DNA or cDNA sequence. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a ⁇ 6-desaturase with the sequences described above and which give the host the ability to overproduce fatty acids, oils or lipids with double bonds in the ⁇ 6-position. These sequences can be of homologous or heterologous origin.
  • These regulatory sequences are intended to enable targeted expression of the genes and protein expression. Depending on the host organism, this can mean, for example, that the gene is only expressed and / or overexpressed after induction, or that it is expressed and / or overexpressed immediately.
  • these regulatory sequences are sequences to which inducers or repressors bind and thus regulate the expression of the nucleic acid.
  • the natural regulation of these sequences may still be present before the actual structural genes and may have been genetically modified so that the natural regulation has been switched off and the expression of the genes increased.
  • the gene construct can also have a simpler structure, that is to say no additional regulation signals have been inserted in front of the nucleic acid sequence or its derivatives, and the natural promoter with its regulation has not been removed. Instead, the natural regulatory sequence was mutated in such a way that regulation no longer takes place and / or gene expression is increased.
  • the gene construct can also advantageously contain one or more so-called "enhancer sequences” functionally linked to the promoter, which enable increased expression of the nucleic acid sequence. Additional advantageous sequences, such as further regulatory elements or terminators, can also be inserted at the 3 'end of the DNA sequences.
  • the regulatory sequences or factors can preferably have a positive influence on the gene expression of the introduced genes and thereby increase it.
  • the regulatory elements can advantageously be strengthened at the transcription level by using strong transcription signals such as promoters and / or "enhancers".
  • an increase in translation is also possible, for example, by improving the stability of the mRNA.
  • promoters which can advantageously control the expression of foreign genes in organisms in plants or fungi are suitable as promoters in the expression cassette.
  • a plant promoter or promoters which originate, for example, from a plant virus are preferably used.
  • Advantageous regulatory sequences for the method according to the invention are, for example, in promoters such as cos, tac, trp, tet, trp-tet, lpp, lac, lpp-lac, lacl ⁇ - T7, T5, T3 -, gal-, trc-, ara-, SP6-, ⁇ -P R - or contained in the ⁇ -P L promoter, which are advantageously used in gram-negative bacteria.
  • the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous ⁇ 6-desaturase gene in the organisms can advantageously be controlled in the plants at a specific point in time.
  • Such advantageous plant promoters are, for example, the PRPl promoter [Ward et al. , Plans. Mol. Biol. 22 (1993), 361-366], one which is inducible by benzenesulfonamide (EP 388186), one which is inducible by tetracycline (Gatz et al., (1992) Plant J. 2,397-404), one inducible by salicylic acid Promoter (WO 95/19443), an abscisic acid-inducible (EP335528) or an ethanol- or cyclohexanone-inducible (WO 93/21334) promoter.
  • plant promoters are, for example, the promoter of the cytosolic FBPase from potato, the ST-LSI promoter from potato (Stockhaus et al., EMBO J. 8 (1989) 2445-245), the promoter of the phosphoribosyl pyrophosphate amidotransferase from Glycine max (see also Genbank Accession Number U87999) or a node-specific promoter as in EP 249676 can advantageously be used. Plant promoters which ensure expression in tissues or plant parts / organs in which fatty acid biosynthesis or its precursors take place, such as, for example, in the endosperm or in the developing embryo, are particularly advantageous.
  • advantageous promoters which ensure seed-specific expression, such as, for example, the USP promoter or derivatives thereof, the LEB4 promoter, the phaseolin promoter or the napin promoter.
  • the 5 and particularly advantageous USP promoter or its derivatives listed according to the invention mediate very early gene expression in seed development (Baeumlein et al., Mol Gen Genet, 1991, 225 (3): 459-67).
  • Further advantageous seed-specific promoters that can be used for monocot and dicot plants are those for dicots
  • suitable promoters such as Napingen promoter from rapeseed (US5, 608, 152), the oleosin promoter from Arabidopsis (WO98 / 45461), the phaseolin promoter from Phaseolus vulgaris (US5, 504, 200), the Bce4- Promoter from Brassica (W091 / 13980) or the legume B4 promoter (LeB4, Baeumlein
  • promoters suitable for monocotyledons such as the promoters, the promoters of the barley Ipt2 or Iptl gene (WO95 / 15389 and WO95 / 23230) or the promoters of the barley Hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which, for example, the biosynthesis of fatty acids, oils and lipids or their precursors takes place. Promoters that ensure seed-specific expression should be mentioned in particular.
  • promoters such as that of the lpt2 or Iptl gene from barley (WO95 / 15389 and WO95 / 23230), which mediat
  • the desaturase genes are advantageously used in the nucleic acid construct.
  • DNA fragments can be manipulated in order to obtain a nucleotide sequence which is expediently read in the correct direction and which is equipped with a correct reading frame.
  • adapters or linkers can be attached to the fragments.
  • the promoter and the terminator regions can expediently in the transcription direction with a linker or polylinker which has one or more restriction sites for the
  • the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites. In general, the linker has a size of less than 100 bp, often less than 60 bp, but at least 5 bp within the regulatory ranges.
  • the promoter can be native or homologous as well as foreign or heterologous to the host organism, for example to the host plant.
  • the expression cassette contains in the 5 '-3' transcription direction the promoter, a DNA sequence which codes for a ⁇ 6-desaturase gene used in the method according to the invention and a region for the transcriptional termination. Different termination areas are interchangeable.
  • Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984), 835 ff) or corresponding functional equivalents.
  • An expression cassette is produced by fusing a suitable promoter with a suitable ⁇ 6-desaturase DNA sequence and a polyadenylation signal according to common recombination and cloning techniques, as described, for example, in T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Ber an and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
  • the DNA sequence coding for a ⁇ 6-desaturase from Phsyco-mitrella patens contains all the sequence features which are necessary in order to achieve a localization correct for the location of the fatty acid, lipid or oil biosynthesis. Therefore no further targeting sequences per se are necessary. However, such a localization can be desirable and advantageous and can therefore be artificially modified or reinforced, so that such fusion constructs are also a preferred advantageous embodiment of the invention.
  • nucleic acid sequences coding for ⁇ 6-desaturase genes are advantageously cloned together with at least one reporter gene into an expression cassette which is introduced into the organism via a vector or directly into the genome. This reporter gene should be easy to detect via a
  • an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the coding sequence for the ⁇ 6-desaturase DNA sequence in between.
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can perform its function as intended in the expression of the coding sequence.
  • the sequences preferred for the operative linkage are targeting sequences to ensure subcellular localization in plastids. But also targeting sequences to ensure subcellular localization in the mitochondrion, in the endoplasmic reticulum
  • ER in the cell nucleus, in oil corpuscles or other compartments can be used if necessary, and translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693- 8711).
  • An expression cassette can contain, for example, a constitutive promoter (preferably the USP or Napin promoter), the gene to be expressed and the ER retention signal.
  • the amino acid sequence KDEL lysine, aspartic acid, glutamic acid, leucine
  • the expression cassette is advantageously inserted into a vector such as, for example, a plasmid, a phage or other DNA, which enables optimal expression of the genes in the host organism.
  • Suitable plasmids are, for example, in E.
  • Advantageous yeast vectors are, for example, 2 ⁇ M, pAG-1, YEp6, YEpl3 or pEMBLYe23.
  • Examples of algae or plant promoters are pLGV23, pGHlac + , pBIN19, pAK2004, pVKH or pDH51 (see Schmidt, R. and Willmitzer, L., 1988).
  • the above-mentioned vectors or derivatives of the above-mentioned vectors represent a small selection of the possible plasmids.
  • vectors are also understood to mean all other vectors known to the person skilled in the art, such as phages, viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
  • phages viruses
  • viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
  • viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
  • viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
  • the expression cassette according to the invention can also advantageously be
  • nucleic acid sequence according to the invention can also be introduced into an organism on its own.
  • nucleic acid sequence according to the invention can all be introduced into the organism together with a reporter gene in a single vector or each individual gene with a reporter gene in each vector or several genes together in different vectors, the different vectors can be introduced simultaneously or successively.
  • the vector advantageously contains at least one copy of the nucleic acid sequences which code for a ⁇ 6-desaturase and / or the expression cassette.
  • the plant expression cassette can be transformed into the transformation vector pRT ((a) Toepfer et al., 1993, Methods Enzymol., 217: 66-78; (b) Toepfer et al. 1987, Nucl. Acids. Res. 15: 5890 ff. ) to be built in.
  • pRT transformation vector
  • Fusion vectors used in prokaryotes frequently use inducible systems with and without fusion proteins or fusion oligopeptides, it being possible for these fusions to take place both at the N-terminal and at the C-terminal or other usable domains of a protein.
  • Such fusion vectors usually serve: i.) To increase the expression rate of the RNA ii.) To increase the achievable protein synthesis rate, iii.) To increase the solubility of the protein, iv. ) or to simplify purification by means of a binding sequence which can be used for affinity chromatography.
  • proteolytic cleavage sites are also introduced via fusion proteins, which enables a part of the fusion protein to be split off, also for purification.
  • recognition sequences for Identifying proteases are, for example, factor Xa, thrombin and enterokinase.
  • Typical advantageous fusion and expression vectors are pGEX [Pharmacia Biotech Ine; Smith, D.B. and Johnson, K.S. (1988) Gene 67: 31-40], pMAL (New England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ) which contains glutathione S-transferase (GST), maltose binding protein, or protein A.
  • GST glutathione S-transferase
  • E. coli expression vectors are pTrc
  • vectors for use in yeast are pYepSecl (Baldari, et al., (1987) Embo J. 6: 229-234), pMFa (Kurjan and Herskowitz, (1982) Cell 30: 933-943), pJRY88 (Schultz et al., (1987) Gene 54: 113-123), and pYES derivatives (Invitrogen Corporation, San Diego, CA).
  • Vectors for use in filamentous mushrooms are described in: van den Hondel, C.A.M.J.J. & Punt, P.J. (1991) "Gene transfer Systems and vector development for filamentous fungi, in: Applied Molecular Genetics of Fungi, J.F. Peberdy, et al., Eds., P. 1-28, Cambridge University Press: Cambridge.
  • insect cell expression vectors can also be used advantageously, e.g. for expression in Sf 9 cells. These are e.g. the vectors of the pAc series (Smith et al. (1983) Mol. Cell Biol. 3: 2156-2165) and the pVL series (Lucklow and Summers (1989) Virology 170: 31-39).
  • plant cells or algal cells can advantageously be used for gene expression.
  • plant expression vectors can be found in Becker, D., et al. (1992) "New plant binary vectors with selectable markers located proximal to the left border", Plant Mol. Biol. 20: 1195-1197 or in Bevan, M.W. (1984) "Binary ⁇ gebbacte ium vectors for plant transformation", Nucl. Acid. Res. 12: 8711-8721.
  • nucleic acid sequences coding for the ⁇ 6-desaturase can be expressed in mammalian cells.
  • Examples of corresponding expression vectors are pCDM8 and pMT2PC mentioned in: Seed, B. (1987) Nature 329: 840 or Kaufman et al. (1987) EMBO J. 6: 187-195).
  • promoters to be used are preferably of viral origin, such as promoters of the polyoma, adenovirus 2, cytomegalovirus or Simian virus 40.
  • Others prokaryotic and eukaryotic expression systems are mentioned in chapters 16 and 17 in Sambrook et al. , Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 5 1989.
  • nucleic acids according to the invention can in principle be carried out by all methods known to the person skilled in the art.
  • transformation The transfer of foreign genes into the genome of a plant is called transformation.
  • the methods described for the transformation and regeneration of plants from 5 plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene cannon - the so-called particle bombardment method -, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and the gene transfer mediated by Agrobacterium.
  • the methods mentioned are described, for example, in B. Jenes et al. , Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. 5 Wu, Academy Press (1993) 128-143 and in Potrykus Annu. Rev.
  • the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 0 12 (1984) 8711).
  • Agrobacteria transformed with such a vector can then be used in a known manner for transforming plants, in particular crop plants, such as tobacco plants, for example, by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • the transformation of plants with Agrobacterium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res.
  • Agrobacteria transformed with an expression vector as described above can also be used in a known manner to transform plants such as test plants such as Arabidopsis or crop plants such as cereals, corn, oats, rye, barley, wheat, soybeans, rice, cotton, sugar beet, canola, triticale, rice, Sunflower, flax, hemp, potato, tobacco, tomato, coffee, cocoa, tea, carrot, paprika, rapeseed, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and wine species, especially oil containing crops such as soy, peanut, castor, borage, flax, sunflower,
  • Canola, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • the genetically modified plant cells can be regenerated using all methods known to the person skilled in the art. Appropriate methods can be found in the above-mentioned writings by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer can be found.
  • all organisms which are able to synthesize fatty acids, especially unsaturated fatty acids or are suitable for the expression of recombinant genes are advantageously suitable as organisms or host organisms for the nucleic acids used, the expression cassette or the vector used.
  • Examples include plants such as Arabidopsis, Asteraceae such as Calendula or crops such as soybean, peanut, castor oil, sunflower, maize, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, microorganisms such as fungi, for example the genus Mortierella, Saprolegnia or Pythium, bacteria such as the genus Escherichia, cyanobacteria, ciliates, Thrausto- or Schizichytria, algae or protozoa such as dinoplagellates such as Crypthecodinium.
  • crops such as soybean, peanut, castor oil, sunflower, maize, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean
  • microorganisms such as fungi, for example the genus Mortierella, Saprolegnia or Pythium,
  • Organisms which can naturally synthesize oils in large quantities such as fungi of the genera Mortierella or Pythium, such as Mortierella alpina, Pythium insidiosum, or plants, such as soybean, rapeseed, coconut, oil palm, color safflower, castor oil, calendula, peanut, cocoa bean or sunflower, are particularly preferred be soybean, rapeseed, sunflower, castor oil, or Mortierella Pythium.
  • transgenic animals are also suitable as host organisms, for example C. elegans.
  • Usable expression strains e.g. those which have a lower protease activity are described in: Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128.
  • the expression of the ⁇ 6-desaturase gene can take place specifically in the leaves, in the seeds, in the tubers or in other parts of the plant.
  • Such fatty acids, oils or lipids with ⁇ 6 double bonds overproducing transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
  • a preferred object according to the invention is transgenic plants, for example crop plants such as corn, oats, rye, wheat, barley, corn, rice, soybeans, sugar beet, canola, triticale, sunflower, flax, hemp, tobacco, tomato, coffee, cocoa, tea, Carrot, bell pepper, rapeseed, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and wine species, potato, in particular oil-containing crops, such as soybean, peanut, castor oil, borage, flax, sunflower, canola , Cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, test plants such as Arabidopsis or other plants such as moss or algae containing a functional nucleic acid sequence according to the invention or a functional expression cassette.
  • Functional means here that an enzymatically active enzyme is formed.
  • the expression cassette or the nucleic acid sequences according to the invention containing a ⁇ 6-desaturase gene sequence can also be used to transform the above-mentioned organisms such as bacteria, cyanobacteria, filamentous fungi, ciliates, animals or algae with the aim of increasing the content of fatty acids, oils or lipids ⁇ 6 double bonds can be used.
  • Preferred transgenic organisms are bacteria, cyanobacteria, filamentous fungi or algae.
  • Transgenic organisms are understood to mean organisms which contain a foreign nucleic acid from another organism which codes for a ⁇ 6-desaturase used in the process according to the invention.
  • Transgenic organisms are also understood to mean organisms which have a nucleic acid which comes from the same organism and which codes for a ⁇ 6-desaturase, whereby this nucleic acid is contained as an additional gene copy or is not contained in the natural nucleic acid environment of the ⁇ 6-desaturase gene.
  • Transgenic organisms are also organisms in which the natural 3 'and / or 5' region of the ⁇ 6-desaturase gene has been changed by targeted genetic engineering changes compared to the parent organism.
  • Transgenic organisms in which a foreign DNA has been introduced are preferred.
  • Transgenic plants into which foreign DNA has been introduced are particularly preferred.
  • Transgenic plants are understood to mean individual plant cells and their cultures, such as callus cultures on solid media or in liquid culture, plant parts and whole plants.
  • transgenic organisms selected from the group of plants, fungi, ciliates, algae, bacteria, cyanobacteria or animals, preferably transgenic plants or algae, which contain at least one isolated nucleic acid sequence which codes for a polypeptide with ⁇ 6-desaturase activity from the group:
  • ⁇ 6 double bonds mean, for example, the artificially acquired ability of an increased biosynthesis capacity through functional overexpression of the ⁇ 6-desaturase gene in the organisms according to the invention advantageously in the transgenic plants according to the invention compared to the non-genetically modified starting plants, at least for the duration of at least one plant generation.
  • the biosynthesis site of fatty acids, oils or lipids is generally the seed or cell layers of the seed, so that a seed-specific expression of the ⁇ 6-desaturase gene is useful.
  • biosynthesis of fatty acids, oils or lipids need not be limited to the seed tissue, but also in all other parts of the plant - for example in epidermal cells or in the tubers - tissue can take place specifically.
  • constitutive expression of the exogenous ⁇ 6-desaturase gene is advantageous.
  • inducible expression may also appear desirable.
  • the effectiveness of the expression of the ⁇ 6-desaturase gene can be determined, for example, in vitro by proliferation of the shoot meristem.
  • a change in the type and level of expression of the ⁇ 6-desaturase gene and its effect on the fatty acid, oil or lipid biosynthesis performance on test plants can be tested in greenhouse experiments.
  • the invention relates to transgenic plants transformed with a nucleic acid sequence which codes for a ⁇ 6-desaturase, a vector or an expression cassette containing a ⁇ 6-desaturase gene sequence or DNA sequences which hybridize therewith, and transgenic cells, tissue , Parts and propagation material of such plants.
  • Transgenic crop plants as described above are particularly preferred.
  • Plants in the sense of the invention are mono- and dicotyledonous plants or algae.
  • SEQ ID N0: 1 sequence or hybridizing DNA sequences for the production of fungi, bacteria, animals or plants, preferably plants with an increased content of fatty acids, oils or lipids with ⁇ 6 double bonds by expression of this ⁇ 6-desaturase DNA sequence in plants ,
  • the cloning processes such as Restriction cleavage, agarose gel electrophoresis, purification of DNA fragments, transfer
  • the sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from ABI according to the method of Sanger (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments resulting from a polymerase chain reaction were sequenced and checked to avoid polymerase errors in constructs to be expressed.
  • Example 3 Lipid analysis from the protonema of P. patens and from yeast cells
  • Yeast cultures transformed with pYES2 (control) and pYESdelta ⁇ ( ⁇ 6-desaturase cDNA) were grown on uracil-dop-out medium with 2% raffinose and 1% tergitol NP-40 (for stabilizing the fatty acids).
  • fatty acids were solubilized in 5% tergitol and added at a final concentration of 0.0003%. The results of the expression are shown in Table I.
  • fatty acids with a double bond at position 6 is only possible in the presence of the expression construct with the ⁇ 6-desaturase cDNA.
  • This ⁇ 6-desaturase enzyme has a greater activity towards fatty acids which already contain a double bond at position 9 or 12 (in relation to the carbon atom in the chain).
  • the fatty acid methyl esters of the entire lipid of the yeast were analyzed by GC.
  • the individual fatty acids synthesized are given in the table in mol% of the total fatty acids.
  • Example 6 Isolation of ⁇ 6-desaturase cDNA and genomic 10 clones from P. patens
  • fragments of a ⁇ 6-desaturase gene were cloned at 20 72 ° C., 5 min.
  • poly (A) RNA was isolated from P. patens Protonema culture 12 days old. The PCR described above was carried out with this poly (A) RNA. Fragments of the expected fragment length (500 to 600 bp) were cloned into pUC18 and
  • the nucleotide sequence is given in SEQ ID NO: 1.
  • the deduced amino acid sequence can be found in SEQ ID NO: 2.
  • the associated genomic sequence is given in SEQ ID NO: 1.
  • Table II shows the results of the comparison between the new P. patens ⁇ 6-desaturase over the entire nucleic acid sequence with the following known ⁇ 6-desaturase: Borago officinalis (U79010), Synechocystis sp (L11421), Spirulina platensis 5 (X87094), Caenorhabiditis elegans ( AF031477), Mortierella alpina (WO 98/46764), Homo sapiens (Cho et al., J. Biol. Chem., 274, 1999: 471-477), Rattus norvegicus (AB021980) and Mus musculus (Cho et al., J. Biol.
  • the genomic ⁇ 6-acyllipid desaturase from Physcomitrella patens was modified based on the published sequence (Girke et al., Plant J., 15, 1998: 39-48) by means of polymerase chain reaction and cloning, isolated and used for the method according to the invention.
  • a desaturase fragment was first isolated using a polymerase chain reaction using two gene-specific primers and into which Girke et al. (see above) Desaturasegen described.
  • Primer TG5 5 '- ccgctcgagcgaggttgttgtggagcggc and primer TG3: 5 ⁇ -ctgaaatagtcttgctcc-3'
  • the promoter-desaturase fragment obtained was cloned into the vector pJH3 by terminating the plasmid pSK with Xhol, treatment with T4-DNA polymerase and PstI restriction.
  • the vector BamHI was cut and the overhangs were filled in with Klenow enzyme and then cut again with PstI. It was created by ligation of the
  • the expression cassette from pJH7 was cut with Bspl20l and Notl and cloned into the binary vector pRE.
  • the plasmid pRE-Ppdes ⁇ was formed.
  • the ⁇ 6-desaturase cDNA from P. patens according to the invention was used as a template in a PCR reaction. With the help of the oligonucleotides listed below, a BamHI restriction site before the start codon and three adenine nucleotides were introduced into the ⁇ 6-desaturase cDNA as consensus translation sequence for eukaryotes. A 1512 base pair fragment of the ⁇ 6-desaturase was amplified and sequenced.
  • Pp-d6Desl 5 '- CC GGTACC aaaatggtattcgcgggcggtg -3'
  • Pp-d6Desl 5 '- CC GGTACC ttaactggtggtagcatgct -3'
  • reaction mixtures contained approx. 1 ng / micro 1 matrices
  • DNA 0.5 UM of the oligonucleotides and, 200 ⁇ M deoxy nucleotides (Pharmacia), 50 mM KC1, 10 mM Tris-HCl (pH 8.3 at 25 ° C, 1.5 mM MgCl 2 > and 0.02 U / ⁇ l Pwo polymerase (Boehringer Mannheim) and are incubated in a PCR machine from Perkin Elmer with the following temperature program:
  • Annealing temperature 50 ° C, 30 sec
  • Elongation temperature 72 ° C, 90 sec
  • the fragment of approximately 1.5 kB base pairs obtained was ligated into the vector pBluescript SK- (Stratagene) which had been cleaved with EcoRV and was available as BamHI fragment for further cloning.
  • pBin-USP contains the BamHI fragment of the ⁇ 6-desaturase.
  • pBin-USP is a derivative of the plasmid pBinl9.
  • pBinUSP originated from pBinl9 by using pBinl9 [Bevan et al. (1980) Nucl. Acids Res. 12, 8711], a USP promoter was inserted as an EcoRI-BaMHI fragment.
  • the polyadenylation signal is that of gene 3 of the T-DNA of the Ti plasmid pTiACH5 (Gielen et al., (1984) EMBO J.
  • nucleotides 11749-11939 being isolated as a PvuII-HindIII fragment and after addition of Sphl -Linkers cloned to the PvuII interface between the SpHI-HindIII interface of the vector.
  • the USP promoter corresponds to nucleotides 1-684 (Genbank Accession X56240), with part of the non-coding region of the USP gene being contained in the promoter.
  • the 684 base pair promoter fragment was amplified using a commercially available T7 standard primer (Stratagene) and using a synthesized primer via a PCR reaction using standard methods (primer sequence: 5 '-GTCGACCCGCGGACTAGTG- GGCCCTCTAGACCCGGGGGATCC GGATCTGCTGGCTATGAA.
  • the PCR fragment was cut with EcoRI / SalI and inserted into the vector pBin19 with OCS terminator.
  • the plasmid called pBinUSP was created.
  • a construct was created using the v-ATPase-cl promoter.
  • the promoter was cloned as an EcoRI / Kpnl fragment into the plasmid pBinl9 with OCS terminator and the ⁇ 6-desaturase gene from P. patens between promoter and via BamHI Terminator advertises.
  • the promoter corresponds to a 1153 base pair fragment from beta-Vulgaris (Plant Mol Biol, 1999, 39: 463-475).
  • the construct was used to transform Arabidopsis thaliana and oilseed rape plants.
  • Example 8 Generation of transgenic rape plants (modified after
  • Petioles or hypocotyledons of freshly sprouted sterile rape plants were incubated in a petri dish with a 1:50 agrobacterial dilution for 5-10 minutes. This was followed by a 3-day incubation in the dark at 25 ° C. on 3MS medium with 0.8% Bacto agar. The cultivation was continued after 3 days with 16 hours of light / 8 hours of darkness and on a weekly basis on MS medium with 500 mg / 1 claforan (Cefotaxi e-sodium), 50 mg / 1 kanamycin, 20 ⁇ M benzylaminopurine ( BAP) and 1.6 g / 1 glucose continued. Growing shoots were transferred to MS medium with 2% sucrose, 250 mg / 1 Claforan and 0.8% Bacto agar. If no roots formed after three weeks, 2-indolebutyric acid was added to the medium as root for growth.
  • 2-indolebutyric acid was added to the medium as root for growth.
  • Regenerated shoots were obtained on 2MS medium with kanamycin and claforan, transferred to soil after rooting and after cultivation, grown in a climatic chamber or in a greenhouse for two weeks, brought to flower, ripe seeds were harvested and analyzed for ⁇ 6-desaturase expression using lipid analyzes. Lines with increased levels or double bonds at the ⁇ 6 position would be identified. In the stably transformed transgenic lines, which functionally expressed the transgene, an increased content of double bonds at the ⁇ 6 position was found in comparison to untransformed control plants.
  • Example 8 Lipid extraction from seeds
  • the plant material was first mechanically homogenized using mortars to make it more accessible for extraction.
  • the cell sediment was hydrolyzed with 1 N methanolic sulfuric acid and 2% dimethoxypropane at 90 ° C. and the lipids were transmethylated.
  • the resulting fatty acid methyl esters (FAME) were extracted into petroleum ether.
  • the extracted FAME were analyzed by gas liquid chromatography with a capillary column (chrome pack, WCOT fused silica, CP-Wax-52 CB, 25 m, 0.32 mm) and a temperature gradient from 170 ° C to 240 ° C in 20 min and 5 min at 240 ° C analyzed.
  • the identity of the fatty acid methyl ester was confirmed by comparison with corresponding FAME standards (Sigma).
  • the identity and the position of the double bond could be determined by suitable chemical derivatization of the FAME mixtures e.g. to 4,4-dimethoxyoxazoline derivatives (Christie, 1997, in: Advances in Lipid Methodology, 4th edition: Christie, Oily Press, Dundee, 119-169, and 1998, gas chromatography-mass spectrometry method, lipids 33: 343- 353) can be further analyzed using GC-MS.
  • the GC analyzes of the fatty acid methyl esters from the transgenic rapeseed, which expressed the ⁇ 6-desaturase in a seed-specific manner, are shown in Table III.
  • the transgenic rapeseed has at least 4.95% ⁇ -linolenic acid in the seed.
  • Table III shows the GC analyzes of the fatty acid methyl esters from mature, transgenic rapeseed which express ⁇ 6-desaturase in a seed-specific manner.
  • the fatty acid composition is given in [mol%] of the total fatty acids. It should be noted that individual plants of the T2 generation, which were obtained from positively transformed and self-grown plants, contain up to 4.95% ⁇ -linolenic acid.
  • Table III GC analyzes of the fatty acid methyl esters of rapeseed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne un procédé amélioré de production d'acides gras insaturés et un procédé de production de triglycérides à teneur plus élevée en acides insaturés. L'invention concerne la production d'un organisme transgénique, de préférence, d'une plante transgénique ou d'un micro-organisme transgénique à teneur plus élevée en acides gras, huiles ou lipides avec doubles liaisons DELTA 6 en raison d'une DELTA -6-désaturase exprimée de la mousse. L'invention concerne également des organismes transgéniques qui contiennent un gène de DELTA 6-désaturase, et l'utilisation des acides gras insaturés et triglycérides ayant une teneur plus élevée en acides gras insaturés obtenus selon le procédé.
PCT/EP2000/006223 1999-07-06 2000-07-04 Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures Ceased WO2001002591A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00952997A EP1190080A1 (fr) 1999-07-06 2000-07-04 PLANTES EXPRIMANT DES GENES DE LA $g(D)6-DESATURASE; HUILES CONTENANT DES ACIDES GRAS POLYINSATURES EXTRAITES DE CES PLANTES ET PROCEDE DE PRODUCTION D'ACIDES GRAS INSATURES
CA002378423A CA2378423A1 (fr) 1999-07-06 2000-07-04 Plantes exprimant des genes de la .delta.6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures
AU65607/00A AU776417B2 (en) 1999-07-06 2000-07-04 Plants expressing delta6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids
US10/019,048 US8835715B1 (en) 2000-06-30 2000-07-04 Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
US14/268,700 US9611441B2 (en) 1999-07-06 2014-05-02 Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34753199A 1999-07-06 1999-07-06
US09/347,531 1999-07-06
DE10030976A DE10030976A1 (de) 2000-06-30 2000-06-30 DELTA6-Desaturasegene exprimierende Pflanzen und PUFAS enthaltende Öle aus diesen Pflanzen und ein Verfahren zur Herstellung ungesättigter Fettsäuren
DE10030976.3 2000-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US34753199A Continuation-In-Part 1999-07-06 1999-07-06

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/019,048 A-371-Of-International US8835715B1 (en) 2000-06-30 2000-07-04 Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
US14/268,700 Continuation US9611441B2 (en) 1999-07-06 2014-05-02 Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids

Publications (1)

Publication Number Publication Date
WO2001002591A1 true WO2001002591A1 (fr) 2001-01-11

Family

ID=26006195

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/006223 Ceased WO2001002591A1 (fr) 1999-07-06 2000-07-04 Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures

Country Status (4)

Country Link
EP (1) EP1190080A1 (fr)
AU (1) AU776417B2 (fr)
CA (1) CA2378423A1 (fr)
WO (1) WO2001002591A1 (fr)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057464A3 (fr) * 2001-01-19 2003-02-27 Basf Plant Science Gmbh Procede pour exprimer des genes de biosynthese dans des graines vegetales a l'aide de genes hybrides d'expression
GB2385852A (en) * 2002-02-27 2003-09-03 Rothamsted Ex Station Delta 6-desaturases from Primulaceae
WO2003093482A3 (fr) * 2002-04-29 2004-11-04 Basf Plant Science Gmbh Procede pour produire des acides gras polyinsatures dans des plantes
EP1527182A4 (fr) * 2002-03-01 2005-12-21 Basf Plant Science Gmbh Methode de production d'acides gras insatures
WO2005080578A3 (fr) * 2004-02-17 2006-04-27 Univ York Enzymes desaturases
US7700833B2 (en) 2002-03-01 2010-04-20 Cornell University Process for the production of unsaturated fatty acids
US7736884B2 (en) 2004-06-04 2010-06-15 Fluxome Sciences A/S Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7834250B2 (en) 2004-04-22 2010-11-16 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
WO2010142522A2 (fr) 2009-06-08 2010-12-16 Basf Plant Science Company Gmbh Nouveaux composants de l'allongement des acides gras et leur utilisation
WO2011006948A1 (fr) 2009-07-17 2011-01-20 Basf Plant Science Company Gmbh Nouvelles désaturases et élongases d'acide gras et leurs utilisations
WO2011023800A1 (fr) 2009-08-31 2011-03-03 Basf Plant Science Company Gmbh Molécules d'acides nucléiques régulatrices pour amplifier l'expression des gènes spécifiques aux semences dans des plantes, favorisant une synthèse accrue d'acides gras polyinsaturés
WO2011064181A1 (fr) 2009-11-24 2011-06-03 Basf Plant Science Company Gmbh Nouvelle désaturase d'acides gras et ses utilisations
WO2011064183A1 (fr) 2009-11-24 2011-06-03 Basf Plant Science Company Gmbh Nouvelle élongase d'acides gras et ses utilisations
WO2011161093A1 (fr) 2010-06-25 2011-12-29 Basf Plant Science Company Gmbh Acyltransférases et leurs applications dans la production d'acides gras
DE112009001585T5 (de) 2008-07-01 2012-02-23 Basf Plant Science Gmbh Promotoren von Brassica napus für samenspezifische Genexpression
WO2012052468A2 (fr) 2010-10-21 2012-04-26 Basf Plant Science Company Gmbh Nouvelles désaturases d'acides gras, élongases, composants d'allongement leurs utilisations
US8629195B2 (en) 2006-04-08 2014-01-14 Bayer Materialscience Ag Production of polyurethane foams
WO2014020533A2 (fr) 2012-08-03 2014-02-06 Basf Plant Science Company Gmbh Nouvelles enzymes, composants enzymatiques et leurs utilisations
US8816111B2 (en) 2012-06-15 2014-08-26 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
EP2821492A2 (fr) 2009-05-13 2015-01-07 BASF Plant Science Company GmbH Acyltransférases et leurs utilisations dans la production d'acide gras
US9718759B2 (en) 2013-12-18 2017-08-01 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US9938486B2 (en) 2008-11-18 2018-04-10 Commonwealth Scientific And Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
US10005713B2 (en) 2014-06-27 2018-06-26 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position
US10513717B2 (en) 2006-08-29 2019-12-24 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (fr) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production d'acide linoleique gamma au moyen d'une δ6-desaturase
WO1998046764A1 (fr) * 1997-04-11 1998-10-22 Calgene Llc Procedes et compositions pour la synthese d'acides gras polyinsatures a chaine longue dans des plantes
WO1999027111A1 (fr) * 1997-11-24 1999-06-03 University Of Bristol Genes de desaturase et leur utilisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (fr) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production d'acide linoleique gamma au moyen d'une δ6-desaturase
WO1998046764A1 (fr) * 1997-04-11 1998-10-22 Calgene Llc Procedes et compositions pour la synthese d'acides gras polyinsatures a chaine longue dans des plantes
WO1999027111A1 (fr) * 1997-11-24 1999-06-03 University Of Bristol Genes de desaturase et leur utilisation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GIRKE, T. ET AL.: "Identification of a novel delta-6-acyl-group desaturase by targeted gene disruption in Physcomitrella patens", THE PLANT JOURNAL, vol. 15, no. 1, July 1998 (1998-07-01), pages 39 - 48, XP000881712 *
SAYANOVA, O. ET AL.: "Expression of a borage desaturase cDNA containing an N-terminal cytochrome b5 domain results in the accumulation of high levels of delta-6-desaturated fatty acids in transgenic tobacco", PROC.NATL.ACAD.SCI.USA, vol. 94, April 1997 (1997-04-01), pages 4211 - 4216, XP002099447 *
SPERLING, P. ET AL.: "A bifunctional delta-6-fatty acyl acetylenase/desaturase from thr moss Ceratodon purpureus", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 267, June 2000 (2000-06-01), pages 3801 - 3811, XP000941309 *

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057464A3 (fr) * 2001-01-19 2003-02-27 Basf Plant Science Gmbh Procede pour exprimer des genes de biosynthese dans des graines vegetales a l'aide de genes hybrides d'expression
GB2385852A (en) * 2002-02-27 2003-09-03 Rothamsted Ex Station Delta 6-desaturases from Primulaceae
EP1527182A4 (fr) * 2002-03-01 2005-12-21 Basf Plant Science Gmbh Methode de production d'acides gras insatures
US7700833B2 (en) 2002-03-01 2010-04-20 Cornell University Process for the production of unsaturated fatty acids
US7893320B2 (en) 2002-04-29 2011-02-22 Basf Plant Science Gmbh Method for producing multiple unsaturated fatty acids in plants
WO2003093482A3 (fr) * 2002-04-29 2004-11-04 Basf Plant Science Gmbh Procede pour produire des acides gras polyinsatures dans des plantes
WO2005080578A3 (fr) * 2004-02-17 2006-04-27 Univ York Enzymes desaturases
US9970033B2 (en) 2004-04-22 2018-05-15 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US8106226B2 (en) 2004-04-22 2012-01-31 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US11597953B2 (en) 2004-04-22 2023-03-07 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US11220698B2 (en) 2004-04-22 2022-01-11 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US10781463B2 (en) 2004-04-22 2020-09-22 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7932438B2 (en) 2004-04-22 2011-04-26 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US8853432B2 (en) 2004-04-22 2014-10-07 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US10443079B2 (en) 2004-04-22 2019-10-15 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US8071341B2 (en) 2004-04-22 2011-12-06 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9994880B2 (en) 2004-04-22 2018-06-12 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US7834250B2 (en) 2004-04-22 2010-11-16 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9453183B2 (en) 2004-04-22 2016-09-27 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US8158392B1 (en) 2004-04-22 2012-04-17 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9458410B2 (en) 2004-04-22 2016-10-04 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US9963723B2 (en) 2004-04-22 2018-05-08 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9951357B2 (en) 2004-04-22 2018-04-24 Commonweatlh Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US9926579B2 (en) 2004-04-22 2018-03-27 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US7736884B2 (en) 2004-06-04 2010-06-15 Fluxome Sciences A/S Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids
US8629195B2 (en) 2006-04-08 2014-01-14 Bayer Materialscience Ag Production of polyurethane foams
US10513717B2 (en) 2006-08-29 2019-12-24 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids
EP2826864A2 (fr) 2008-07-01 2015-01-21 BASF Plant Science GmbH Promoteurs dérivés de brassica napus pour l'expression génique spécifique de semences
DE112009001585T5 (de) 2008-07-01 2012-02-23 Basf Plant Science Gmbh Promotoren von Brassica napus für samenspezifische Genexpression
US9938486B2 (en) 2008-11-18 2018-04-10 Commonwealth Scientific And Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
EP2821492A2 (fr) 2009-05-13 2015-01-07 BASF Plant Science Company GmbH Acyltransférases et leurs utilisations dans la production d'acide gras
WO2010142522A2 (fr) 2009-06-08 2010-12-16 Basf Plant Science Company Gmbh Nouveaux composants de l'allongement des acides gras et leur utilisation
US8993841B2 (en) 2009-06-08 2015-03-31 Basf Plant Science Company Gmbh Fatty acid elongation components and uses thereof
DE112010002353T5 (de) 2009-06-08 2012-08-09 Basf Plant Science Company Gmbh Neue fettsäure-elongations-komponenten und anwenduingen davon
DE112010002967T5 (de) 2009-07-17 2012-10-11 Basf Plant Science Company Gmbh Neue Fettsäuredesaturasen und -elongasen und Anwendungen davon
WO2011006948A1 (fr) 2009-07-17 2011-01-20 Basf Plant Science Company Gmbh Nouvelles désaturases et élongases d'acide gras et leurs utilisations
WO2011023800A1 (fr) 2009-08-31 2011-03-03 Basf Plant Science Company Gmbh Molécules d'acides nucléiques régulatrices pour amplifier l'expression des gènes spécifiques aux semences dans des plantes, favorisant une synthèse accrue d'acides gras polyinsaturés
EP3418387A1 (fr) 2009-08-31 2018-12-26 Basf Plant Science Company GmbH Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression de gènes spécifiques des semences dans des plantes pour faciliter la synthèse améliorée d'acides gras polyinsaturés
EP3121283A1 (fr) 2009-08-31 2017-01-25 BASF Plant Science Company GmbH Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression de gènes spécifiques des semences dans des plantes de promotion de la synthèse d'acides gras polyinsaturés améliorée
EP3178937A1 (fr) 2009-08-31 2017-06-14 BASF Plant Science Company GmbH Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression de gènes spécifiques des semences dans des plantes pour faciliter la synthèse améliorée d'acides gras polyinsaturés
WO2011064183A1 (fr) 2009-11-24 2011-06-03 Basf Plant Science Company Gmbh Nouvelle élongase d'acides gras et ses utilisations
WO2011064181A1 (fr) 2009-11-24 2011-06-03 Basf Plant Science Company Gmbh Nouvelle désaturase d'acides gras et ses utilisations
WO2011161093A1 (fr) 2010-06-25 2011-12-29 Basf Plant Science Company Gmbh Acyltransférases et leurs applications dans la production d'acides gras
WO2012052468A2 (fr) 2010-10-21 2012-04-26 Basf Plant Science Company Gmbh Nouvelles désaturases d'acides gras, élongases, composants d'allongement leurs utilisations
US9458477B2 (en) 2010-10-21 2016-10-04 Basf Plant Science Company Gmbh Fatty acid desaturases, elongases, elongation components and uses thereof
DE112011103527T5 (de) 2010-10-21 2013-10-17 Basf Plant Science Company Gmbh Neue Fettsäure-Desaturasen, -Elongasen, -Elongations-Komponenten und Anwendungen davon
EP2695936A1 (fr) 2010-10-21 2014-02-12 BASF Plant Science Company GmbH Nouvelles désaturases d'acides gras et leurs utilisations
US9556102B2 (en) 2012-06-15 2017-01-31 Commonwealth Scientific And Industrial Research Organisation Process for producing ethyl esters of polyunsaturated fatty acids
US9932289B2 (en) 2012-06-15 2018-04-03 Commonwealth Scientific And Industrial Research Ogranisation Process for producing ethyl esters of polyunsaturated fatty acids
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
US8816111B2 (en) 2012-06-15 2014-08-26 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US9550718B2 (en) 2012-06-15 2017-01-24 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US10335386B2 (en) 2012-06-15 2019-07-02 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
WO2014020533A2 (fr) 2012-08-03 2014-02-06 Basf Plant Science Company Gmbh Nouvelles enzymes, composants enzymatiques et leurs utilisations
US9718759B2 (en) 2013-12-18 2017-08-01 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US9725399B2 (en) 2013-12-18 2017-08-08 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10190073B2 (en) 2013-12-18 2019-01-29 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10800729B2 (en) 2013-12-18 2020-10-13 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10125084B2 (en) 2013-12-18 2018-11-13 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US11623911B2 (en) 2013-12-18 2023-04-11 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US10793507B2 (en) 2014-06-27 2020-10-06 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position
US10005713B2 (en) 2014-06-27 2018-06-26 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position

Also Published As

Publication number Publication date
AU6560700A (en) 2001-01-22
EP1190080A1 (fr) 2002-03-27
CA2378423A1 (fr) 2001-01-11
AU776417B2 (en) 2004-09-09

Similar Documents

Publication Publication Date Title
DE60309136T2 (de) Delta 6-desaturase aus primulacaea, pflanzen, exprimierende pflanzen, und öle, welche mehrfach ungesättigte fettsäuren enthalten
EP1613744B1 (fr) Plantes exprimant des delta-4-desaturases provenant d'euglena gracilis et huiles contenant des acides gras polyinsatures (pufa)
EP1181373B1 (fr) Delta6-acetylenase et delta6-desaturase obtenues a partir de ceratodon purpureus
EP1190080A1 (fr) PLANTES EXPRIMANT DES GENES DE LA $g(D)6-DESATURASE; HUILES CONTENANT DES ACIDES GRAS POLYINSATURES EXTRAITES DE CES PLANTES ET PROCEDE DE PRODUCTION D'ACIDES GRAS INSATURES
EP1599582B1 (fr) Procede de production d'acides gras polyinsatures
EP1356067B1 (fr) Procede de production d'acides gras polyinsatures, nouveaux genes biosynthetiques et nouvelles constructions d'expression vegetales
EP2180046B1 (fr) Procédé de production d'acides gras à longues chaînes multi-insaturés dans des organismes transgéniques
DE10219203A1 (de) Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in Pflanzen
DE10102338A1 (de) Verfahren zur Expression von Biosynthesegenen in pflanzlichen Samen unter Verwendung von neuen multiplen Expressionskonstrukten
EP2046960A1 (fr) Procédé de fabrication d'acide arachidonique et/ou d'acide eicosapentaénoïque dans des plantes
EP1945775B1 (fr) Procede pour produire de l'acide gamma-linolenique et/ou de l'acide stearidonique dans des brassicacees et linacees transgeniques
CN100412197C (zh) 生产多不饱和脂肪酸的方法
US9611441B2 (en) Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
DE19962409A1 (de) DELTA6-Acetylenase und DELTA6-Desaturase aus Ceratodon purpureus
Napier et al. Novel Method For The Production Of Polyunsaturated Fatty Acids (Patent EP 1576166 B1)
WO2004007732A1 (fr) Clonage et caracterisation d'une lipoxygenase extraite de phaeodactylum tricornutum
DE10203713A1 (de) Neues Elongasegen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10019048

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2000952997

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2378423

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 65607/00

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000952997

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 65607/00

Country of ref document: AU